The State of Next Generation Sequencing, in a Glimpse

The State of Next Generation Sequencing, in a Glimpse

A look into the state of things NGS-related with a brief selection of the industry's major players. Plus, an announcement regarding the AACC's 2018 meeting in Chicago.


5 Facts About the Next-Generation Sequencing Market in 2018

5 Facts About the Next-Generation Sequencing Market in 2018

From a focus on a consumables, to new sleek benchtop models, to the surpisingly tenacity of old systems, we review the top insights from Kalorama Information's latest report on the industry.


High-Sensitivity Cardiac Tests Find a U.S. Market

High-Sensitivity Cardiac Tests Find a U.S. Market

High-sensitivity troponin tests to diagnose heart attacks have been available in Europe, Canada, and other parts of the world for several years, and on the cobas 4 11 e analyzer in the U.S.. Now, some are predicting two or three others may be approved this year. How these tests work, their limitations in this article.


On Our Radar: WSJ Article on OR and Doctor-Patient Changes, New Proof on Telehealth

On Our Radar: WSJ Article on OR and Doctor-Patient Changes, New Proof on Telehealth

A few news articles that got our attention - a large healthcare IT section in the Wall Street Journal is gaining buzz. And a healthcare system's experience with saving money using telehealth may be a boon to devicemakers.

  • by Bruce Carlson
  • May 21 2018


EHR - Nearing 30 Billion in Revenue

EHR - Nearing 30 Billion in Revenue

Healthcare IT news media is abuzz about our latest report with market sizing and market research findings. We survey some recent articles based on Kalorama's EMR market determination, and look at differences with other sources.


Lab Test Harmonization Gets a $2 Million Boost

Lab Test Harmonization Gets a $2 Million Boost

Recently the AACC released a statement applauding $2 million in funding given to the CDC to advance the cause of harmonizing and standardizing clinical lab test results. The pathology community has been pursuing this for decades, in the name of improving diagnoses and treatment as well as to reduce health care costs.


What Clinical Sequencing Needs

What Clinical Sequencing Needs

Despite the advances in NGS technologies, their successful application and translation to clinical diagnostics must overcome various challenges, detailed in this article.


China's IVD Market: An Opportunity For Surplus Revenue Growth

China's IVD Market: An Opportunity For Surplus Revenue Growth

China represents the most attractive IVD market in the developing world and among developing nations. Additionally, the Chinese IVD market has been and is projected to be the fastest growing among the top-ten national IVD markets. This article describes the opportunity in China and the reasons it's market continues to show better-than-world-average growth.


The CRISPR Diagnostic Toolkit Gets Handier

The CRISPR Diagnostic Toolkit Gets Handier

A new platform based on the gene editing technique is unveiled, and an old-but-still-pretty-new method gets an update. Plus, a CRISPR-related retraction.


Outsourced Drug Discovery Market is Up 17% Per Our Eighth Edition Study of the CRO Market

Outsourced Drug Discovery Market is Up 17%  Per Our Eighth Edition Study of the CRO Market

Increased demand for pharmaceutical "blockbusters," or even middle-of-the-road revenue earners, is fueling the need for outsourcing. Patent expiration and increased demand for R&D, when many firms have laid off workers in R&D, adds up to business for CROs. A trend we've been noticing since 2002. Current status in our most recent report.